Breaking News
1 minute ago
Vaibhavi M.
GSK acquires RAPT Therapeutics to strengthen its allergy pipeline with ozureprubart, a long-acting anti-IgE therapy for food allergies.
Vaibhavi M.
Peptinovo Biopharma secures Australian ethics approval to launch first-in-human clinical trials for its PALM™ cancer platform.
Simantini Singh Deo
Rein Therapeutics secures EMA orphan drug designation for LTI-03, strengthening its path in idiopathic pulmonary fibrosis.
Simantini Singh Deo
Rentschler Biopharma reshapes its Executive Board, naming Uwe Buecheler interim CEO to guide the next phase of growth.
Simantini Singh Deo